治療用化合物およびその使用

Japanese Patent JP6636031

B2

and salts thereof and compositions and uses thereof. The compounds are useful as inhibitors of LSD1. Also included are pharmaceutical compositions comprising a compound of formula I or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various LSD1-mediated disorders.

Albrecht, Brian Kay.
Odya, James Edmond
Coat, alexander
Duplessis, Martin
Gering, Victor S.
Good, Andrew Charles
Hermange, Jean-Christophe
Leblanc, eve
Nasveschak, Christopher Gee.
Taylor, Alexander M.
Vaswani, Lissi.

JP2017539594A

January 29, 2020

January 28, 2016

Click for automatic bibliography generation  

Genentech, Incorporated

C07C211/42; A61K31/135; A61K31/145; A61K31/166; A61K31/192; A61K31/275; A61K31/337; A61K31/351; A61K31/365; A61K31/395; A61K31/40; A61K31/4045; A61K31/407; A61K31/415; A61K31/4155; A61K31/4196; A61K31/436; A61K31/438; A61K31/44; A61K31/4418; A61K31/445; A61K31/4545; A61K31/4743; A61K31/4747; A61K31/495; A61K31/513; A61K31/517; A61K31/519; A61K31/5377; A61K31/565; A61K31/69; A61K31/704; A61K33/24; A61K38/06; A61K38/12; A61K38/44; A61K39/00; A61K39/395; A61K45/00; A61P35/00; A61P43/00; C07C217/74; C07C229/50; C07C237/48; C07C255/58; C07C317/34; C07D211/46; C07D213/36; C07D213/81; C07D221/20; C07D225/06; C07D231/12; C07D239/553; C07D239/94; C07D249/08; C07D273/08; C07D295/185; C07D295/192; C07D305/08; C07D305/14; C07D307/88; C07D309/04; C07D401/04; C07D401/12; C07D403/06; C07D405/12; C07D471/04; C07D475/04; C07D491/044; C07D491/08; C07D493/04; C07D493/22; C07D498/18; C07H15/252; C07H17/04; C07J31/00

JP2007519640A
JP2014532619A
JP2013525318A
JP2014515013A

CN106045862A
WO2017109061A1
WO2010143582A1
WO2013022047A1

DATABASE REGISTRY [ONLINE] Retrieved from STN,2015年,検索日 23 OCT 2019

Hidesaku Yamamoto
Natsuki Morishita

Previous Patent: 試料トランスファ装置

Next Patent: 熱可塑性繊維材料およびその製造方法